Search

Meeting Coverage:

Association for Research in Vision & Ophthalmology

ARVO: 2018

A Future Role in Retina for Stem Cell and Gene Therapy?

Baruch D. Kuppermann, MD, PhD, Nathan C. Steinle, MD

Show Description +

The role of stem cell and gene therapy in ophthalmology is evolving. Nathan C. Steinle, MD, and Baruch D. Kuppermann, MD, PhD, offer their insights on where they see these technologies coming into play in treating blindness and severe diseases of the posterior segment.

Posted: 5/01/2018

Keywords:

Gene Therapy

•

stem cell therapy

Up Next

Predictive Data From the HAWK and HARRIER Studies

Predictive Data From the HAWK and HARRIER Studies

A New Approach to Deviation Mapping for Retinal Perfusion

A New Approach to Deviation Mapping for Retinal Perfusion

Richard B. Rosen, MD

Early Experiences and Outcomes With Pneumatic Retinopexy vs. Future Use

Early Experiences and Outcomes With Pneumatic Retinopexy vs. Future Use

Glenn C. Yiu, MD, PhD

Baseline Features and Treatment Outcomes in Wet AMD

Baseline Features and Treatment Outcomes in Wet AMD

Nathan C. Steinle, MD

Digital Disruptions in Ophthalmology

Digital Disruptions in Ophthalmology

John B. Miller, MD, Roger A. Goldberg, MD, MBA

Getting Better at Treating Diabetic Retinopathy

Getting Better at Treating Diabetic Retinopathy

Nadia K. Waheed, MD, MPH, William F. Mieler, MD

DME Treatment Patterns

DME Treatment Patterns

Jeffrey R. Willis, MD, PhD

Quarterly Dosing and AMD: A Cross-Trial Comparison

Quarterly Dosing and AMD: A Cross-Trial Comparison

David A. Eichenbaum, MD

Real-World Outcomes of nAMD Treated With Anti-VEGF Therapy

Real-World Outcomes of nAMD Treated With Anti-VEGF Therapy

Thomas A. Ciulla, MD, MBA

Results From the STOMP-CSC Trial

Results From the STOMP-CSC Trial

Roger A. Goldberg, MD, MBA

Five-Year Rates of Diabetic Retinopathy Progression

Five-Year Rates of Diabetic Retinopathy Progression

Andrew A. Moshfeghi, MD, MBA

A New Approach to Managing Macular Holes?

A New Approach to Managing Macular Holes?

Daniel Su, MD

Back to All Videos

A Future Role in Retina for Stem Cell and Gene Therapy?

Baruch D. Kuppermann, MD, PhD, Nathan C. Steinle, MD

The role of stem cell and gene therapy in ophthalmology is evolving. Nathan C. Steinle, MD, and Baruch D. Kuppermann, MD, PhD, offer their insights on where they see these technologies coming into play in treating blindness and severe diseases of the posterior segment.

Posted: 5/01/2018

Keywords:

Gene Therapy

•

stem cell therapy

Please log in to leave a comment.

More From ARVO: 2018 Coverage

Results From the STOMP-CSC Trial

Results From the STOMP-CSC Trial

Roger A. Goldberg, MD, MBA

Five-Year Rates of Diabetic Retinopathy Progression

Five-Year Rates of Diabetic Retinopathy Progression

Andrew A. Moshfeghi, MD, MBA

A New Approach to Managing Macular Holes?

A New Approach to Managing Macular Holes?

Daniel Su, MD

Predictive Data From the HAWK and HARRIER Studies

Predictive Data From the HAWK and HARRIER Studies

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARVO: 2018.